Menu
ncarol.com
  • Home
  • Books
  • Book Release
  • Health
  • Business
  • Financial
  • Arts
  • Manufacturing
  • Real Estate
ncarol.com

Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare
ncarol.com/10258250

Trending...
  • From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
  • Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
DURHAM, N.C., April 16, 2024 ~ Prime Healthcare and EmVenio Research have joined forces to launch the EmVenio Research Center at Prime Healthcare, a new initiative that aims to improve access to clinical research for patients while also expanding the research capabilities of Prime Healthcare hospitals.

EmVenio Research, a community research provider, will now have the opportunity to conduct research at Prime Healthcare hospitals and offer patients improved access to clinical trials. This partnership is expected to increase participation in clinical trials by creating awareness of research within communities and providing local access to global research opportunities.

With 44 hospitals and over 300 outpatient locations across the United States, Prime Healthcare is one of the nation's leading health systems. Known for its commitment to quality excellence and innovation, Prime Healthcare will provide the necessary infrastructure and clinical support for EmVenio Research to conduct advanced clinical trials.

Through this collaboration, EmVenio will work with Prime Healthcare hospitals to identify potential candidates for clinical trials using Health Wizz. This secure platform connects with Electronic Health Records (EHR) systems, protecting patient data while streamlining the process of identifying, screening, and enrolling study participants. All data collected will be kept secure and used only with patient consent.

More on ncarol.com
  • Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
  • 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
  • Scott G. Hoy of Hoy Law Earns 11th Consecutive Super Lawyers Selection
  • L2 Aviation Selected for U.S. Air Force KC-46 CASPER Multiple Award Contract
  • Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH

Thad Wolfram, President of EmVenio Research, expressed his excitement about this partnership stating that their priority is delivering value to communities while successfully enrolling and retaining patients for their customers. He believes that through this collaboration with Prime Healthcare and Health Wizz, EmVenio will expand its community-based research footprint and be able to recruit an ever-growing patient base for clinical trials.

Dr. Sunny Bhatia, President and Chief Medical Officer of Prime Healthcare, also shared his enthusiasm about this partnership. He believes that EmVenio's expertise in designing and implementing clinical studies will keep the EmVenio Research Center at Prime Healthcare at the forefront of medical research and discovery. Dr. Bhatia hopes that by offering these opportunities to patients at Prime hospitals, they will have better clinical experiences and outcomes.

Nitin Desai, MD, President and Chief Medical Officer of Health Wizz, also expressed his pride in being a part of this visionary collaboration. He believes that by integrating their technology solutions, they can enhance the efficiency and security of enrolling study participants in clinical trials, ultimately benefiting both patients and researchers.

More on ncarol.com
  • Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
  • KeysCaribbean Resorts Offer Savings On Summer Vacations Now Through Aug. 31
  • Crossroads4Hope Announces The Lipschutz Women's Fund
  • Handmade Coverlet Returns Home to Piedmont Crossing
  • AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)

The EmVenio Research Center at Prime Healthcare will make clinical research available to patients at Prime hospitals across the country, starting with California, Alabama, Texas, and Georgia. This will provide clinical trial sponsors and Contract Research Organizations (CROs) with access to a large and diverse patient population that was previously unavailable to them. With the detailed data available through this partnership, it is expected that there will be improved study feasibility, leading to reduced screen failure rates and increased enrollment certainty.

This service offering includes a hybrid approach that seamlessly integrates brick-and-mortar sites, mobile sites, and in-home research. This unique collaboration between EmVenio Research, Prime Healthcare, and Health Wizz marks a significant milestone in EmVenio's evolution and service repertoire.

Wolfram believes that the EmVenio Research Center at Prime Healthcare will set them apart for patients, communities, partners, and clients alike. This partnership is expected to bring about positive changes in the world of clinical research by providing better opportunities for patients while also expanding research capabilities for healthcare providers.
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
  • From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
  • NVM Pet Announces Leadership Transition, Promotes Next Generation of Executive Leadership
  • U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
  • Valgar LLC Launches The Briefing Room: Education Leaders
  • New from Regal House Publishing, St. Ulphia's Dead, a dark comedy in the magical realist tradition
  • New Novel WINCE Takes Unflinching Aim at American Gun Culture and Masculinity
  • New Research Puts the Cost of Enterprise Decision Delay at $630 Billion a Year Across the Global 2000
  • Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
  • Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
  • New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
  • Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
  • First Flight Society Celebrates National Aviation Day 2026 on Wednesday, August 19th
  • Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
  • Nina Simone and Samuel Waymon Music Scholarship Fund Opens 2026/27 Application Cycle
  • Fatal FOMO May be Your Last Roll of the Dice
  • Inlow Upholstery Offers Dining Chair Reupholstery for Cleveland County Homeowners
  • Financial Visionary Kevin Foushee Expands Impact Through MTM LLC and Client-First Advisory Services
  • Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
_catLbl0 _catLbl1

Popular on ncarol.com

  • RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project - 145
  • BumblebeeSmart Announces Partnership with Extreme Kids World to Expand Access to Sensory Wall Panels and Educational Busy Boards - 112
  • Wagga Trucks set to expand to the Canberra Region as authorised dealer for Volvo, UD & Mack along with Freighter Group Trailers - 108
  • UK Financial Ltd. Opens Test-Phase Maya 3 Liquidity Pool on Uniswap with DEX Screener Visibility for Market-Smoothing Ahead of CATEX Exchange Launch - 104
  • OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
  • Director Sean McNamara Reunites with Award-Winning Cinematographer Shawn Seifert for Upcoming Feature Home
  • Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
  • Landmark Construction Expands Glass, Glazing, and Commercial Remodeling Services Across Los Angeles County and Surrounding Areas
  • Contracting Resources Group Recognized by The Daily Record as a 2026 In the Lead: Best Women-Owned Businesses Honoree

Similar on ncarol.com

  • $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
  • Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
  • Crossroads4Hope Announces The Lipschutz Women's Fund
  • AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
  • Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
  • Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
  • CRG Awarded NASA SEWP VI Contracts in Categories B and C
  • Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
  • From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute